FASN and diffuse large B-cell lymphoma: Given that the overexpressed FASN served as the molecular marker of unfavorable prognosis and malignant progression in multiple cancers,6 we sought to investigate its potential impact on the development and prognosis of diffuse large B-cell lymphoma (DLBCL).